City
Epaper

Omicron a serious issue, India has taken it very seriously: Dr Mohan Gupte

By ANI | Updated: December 15, 2021 22:55 IST

Omicron is a differently mutated virus and India has taken the variant very seriously, said Dr Mohan Gupte (retd), the founder-director of ICMR Epidemiology Department in Chennai on Wednesday.

Open in App

Omicron is a differently mutated virus and India has taken the variant very seriously, said Dr Mohan Gupte (retd), the founder-director of ICMR Epidemiology Department in Chennai on Wednesday.

"As far as India is concerned, we have taken Omicron very seriously. India had some time to respond and are keeping everything ready in case we get a large number of cases and they need some hospitalisation," Dr Gupte told ANI.

As the cases of Omicron have seen a surge, Dr Gupte said that it is a "serious issue."

However, as per the observation of cases in South Africa, where Omicron first emerged, Dr Gupte said that it is a "very mild type of disease" adding that it is still an early stage.

Dr Gupte further stressed that there is "no reason to be afraid" on Omicron being detected in children.

"In children, the disease seems to be very mild. Severities are low. There is hardly any hospitalisation. There is no mortality at all," he said.

According to Dr Gupte, there are "conflicting reports" on how vaccines are going to work on Omicron.

"Omicron is a differently mutated virus. In the context of Omicron, we are not sure how the vaccines are going to work. Some reports state that a booster dose will increase immunity and the severity of the diseases will go down. Some also state that infection cannot be prevented. There are some other reports which stated that with so many mutations, 32 mutations in the spike protein, we cannot take things for granted," Dr Gupte said.

Noting that the virus cannot be taken for granted, especially in case of those having comorbidities, Dr Gupte said booster dose should be given to such categories.

As for the decision on vaccines for children, Dr Gupte said, "We expect that in about six months' time, vaccines for children should be available. There are developments already. As far as Covaxin is concerned, it's ready. They have demonstrated very efficacious results in children."

( With inputs from ANI )

Disclaimer: This post has been auto-published from an agency feed without any modifications to the text and has not been reviewed by an editor

Tags: Icmr epidemiology departmentindiachennaiIndiUk-indiaRepublic of indiaIndia indiaGia indiaMadras missionIndia euThe ppp
Open in App

Related Stories

NationalOperation Sindhu: “We Saw Drones, Missiles,” Say Evacuated Students Recounting Life in Iran’s Warzone

NationalCOVID-19 Update: Mumbai Cases Drop Sharply; India’s Active Tally Drops By 428

EntertainmentSurreal to Be Honoured Where I Once Studied, Says Atlee on Receiving Doctorate by Sathyabama University

CricketIndia vs India A Intra-Squad LIVE Streaming: When and Where To Watch Intra-Squad Match on TV and Online?

NationalChennai Metro Construction Tragedy: Pillar Collapse Near Ramapuram Kills One; Probe Ordered

National Realted Stories

NationalGujarat by-polls: Visavadar and Kadi witness over 54 pc voter turnout

NationalStampede tragedy: Karnataka govt proposes new crowd control law with jail for violations

NationalHeavy rains lash Rajasthan, flood streets in Jaipur

NationalChintan Research Foundation to focus on evidence-based research: Pranav Adani

NationalGujarat Police nab over 200 illegal Bangladeshi immigrants, deportation process underway